N3′→P5′ Thiophosphoramidate / Nucleoside Intermediates
3'-NH₂-ddC
Quick view. A cytosine nucleoside analog bearing a 3'-amino group, no 2'-hydroxyl group, and an unprotected 5'-hydroxyl group. CAS 84472-90-2. Catalog target purity: Specification by inquiry. Availability: Inquiry only — contact OROGO to confirm current availability.
Request a quote Review request checklist
Catalog status
Scope. "Available for inquiry" is not a stock claim. Operating tier is a catalog-merchandising priority. Development phase and program context are shown only where the reviewed catalog source provides a mapping; they describe the chemistry platform and do not claim that OROGO supplies the named program. Annual demand is a planning-model estimate from the reviewed demand dataset, not OROGO sales, inventory, a guaranteed market size or a supply commitment.
| Supply status | Available for inquiry |
|---|---|
| Operating tier | Core |
| Reviewed supporting program count | 1 |
| Representative chemistry-platform program | imetelstat |
| Planning-model annual demand | 3.5 kg/year |
| Demand estimate basis | Planning model: current marketed plus clinical-stage programs |
| Highest development phase | Marketed |
| CAS status | Published registry number |
Product profile
3'-NH₂-ddC is classified as n3′→p5′ thiophosphoramidate / nucleoside intermediates (Formula C9H14N4O3; molecular weight 226.23).
3'-NH₂-ddC is supplied for research use within the Amino-modified Nucleosides product family.
For 3'-NH₂-ddC, confirm the current specification, storage conditions and downstream-method compatibility before routine use.
Names and search terms
Confirmed or normalized name variants
- 3'-Amino-2',3'-dideoxycytidine
Useful catalog search terms
- CAS 84472-90-2
Physicochemical data
| InChIKey | LDQAHTVPOZCQNH-UHFFFAOYSA-N |
|---|---|
| Nucleobase | Cytosine |
| Sugar modification | 2',3'-dideoxy with 3'-amino substitution |
| Hydroxyl state | 5' hydroxyl group unprotected |
| InChI | InChI=1S/C9H14N4O3/c10-5-3-8(16-6(5)4-14)13-2-1-7(11)12-9(13)15/h1-2,5-6,8,14H,3-4,10H2,(H2,11,12,15) |
| SMILES | N=c1ccn(C2CC(N)C(CO)O2)c(O)n1 |
Release documentation
The current specification defines the analytical method and acceptance criteria; the released lot result is reported on the CoA.
Additional HPLC, MS or NMR documentation can be agreed during technical review where available.
Related products
3'-NH₂-ddA
Amino-modified Nucleosides · CAS: 7403-25-0
OR-MN-00083'-NH₂-ddG
Amino-modified Nucleosides · CAS: 66323-49-7
OR-AMN-00693'-Amino-3'-deoxythymidine
Amino-modified Nucleosides · CAS: 52450-18-7
OR-AMN-0132N4-Benzoyl-3'-amino-2',3'-dideoxycytidine
Amino-modified Nucleosides · CAS: 1418009-22-9
OR-AMN-0133N6-Benzoyl-5'-O-DMTr-2'-O-[2-(methylamino)-2-oxoethyl]adenosine
Amino-modified Nucleosides · CAS: 1025783-21-4
Product-family literature
These publications provide peer-reviewed context for the Amino-modified Nucleosides product family and its named chemistry. They are background reading only, not evidence for the exact product, supplied form, lot specification, availability or performance.
Request a quote Review request checklist
Technology platforms
Catalog-derived platform membership for navigating related chemistry and verifiable product sets.